Evidence map›Paper›PMID 41415605›Full record

ArticleArXiv2025

Hierarchical Molecular Language Models (HMLMs).

Hasi Hays, Yue Yu, William J Richardson

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hasi HaysDepartment of Chemical Engineering, University of Arkansas, Fayetteville, AR 72701, USA.ORCID 0000-0003-0843-050X
Yue YuDepartment of Mathematics, Lehigh University, Bethlehem, PA 18015, USA.ORCID 0000-0002-9150-3986
William J RichardsonDepartment of Chemical Engineering, University of Arkansas, Fayetteville, AR 72701, USA.ORCID 0000-0001-8678-9716

Funding

Integrate Data-Driven Modeling and Multi-scale Measures Towards Tissue FunctionR01GM157589 · NIGMS · LEHIGH UNIVERSITY · PI YUE YU · 2024 to 2026
$890k
NIGMS NIH HHS R01 GM157589
6 · The paper itself

Abstract

Artificial intelligence (AI) is reshaping computational and network biology by enabling new approaches to decode cellular communication networks. We introduce Hierarchical Molecular Language Models (HMLMs), a novel framework that models cellular signaling as a specialized molecular language, where signaling molecules function as tokens, protein interactions define syntax, and functional consequences constitute semantics. HMLMs employ a transformer-based architecture adapted to accommodate graph-structured signaling networks through information transducers, mathematical entities that capture how molecules receive, process, and transmit signals. The architecture integrates multi-modal data sources across molecular, pathway, and cellular scales through hierarchical attention mechanisms and scale-bridging operators that enable information flow across biological hierarchies. Applied to a complex network of cardiac fibroblast signaling, HMLMs outperformed traditional approaches in temporal dynamics prediction, particularly under sparse sampling conditions. Attention-based analysis revealed biologically meaningful crosstalk patterns, including previously uncharacterized interactions between signaling pathways. By bridging molecular mechanisms with cellular phenotypes through AI-driven molecular language representation, HMLMs establish a foundation for biology-oriented large language models (LLMs) that could be pre-trained on comprehensive pathway datasets and applied across diverse signaling systems and tissues, advancing precision medicine and therapeutic discovery.

Indexed as

Artificial intelligenceLLMsMolecular languageNetwork modelingPrecision medicine

Identifiers

PMID41415605
PMCPMC12709492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.